Contact Us

Important milestones

  • access_time 1986

    Foundation of BiosChile Ingeniería Genética S.A.

  • access_time 1991

    BiosChile establishes Austral Biologicals, a subsidiary in San Ramón, California, to sell products for biomedical research.

  • grade

    access_time 1992

    The company receives the V Centenario award in the small companies category, granted by the Ibero-American program in Science and Technology, which is given to the most innovative companies.

  • done_all

    BiosChile launches its ELISA test for the detection of antibodies against Chagas disease that has been commercialized since then throughout Latin America. To this is added the development of reagents for blood typing and several diagnostic tests for infectious diseases, such as He-Py Test TM , for the detection of Helicobacter pylori in gastric biopsies, and RotaclonTM, a rapid test for the detection of Rotavirus, among others.

  • access_time 1997

    The first product for the detection of pathogens in salmon is launched. Since then, BiosChile has developed a complete line of tests to detect numerous bacteria and viruses that affect salmon, providing an important tool to the salmon industry.

  • thumb_up

    access_time 2001

    BiosChile signs an agreement with the Spanish group CH- Werfen, which results in the establishment in Chile of BiosWerfen S.A., which will be in charge of distributing the diagnostic products manufactured by both parties.

  • grade

    access_time 2002

    Dr. Pablo Valenzuela, Chairman of the Board of GrupoBios, receives the National Award for Applied Sciences and Technology for his important contribution to the area.

  • grade

    access_time2004

    Dr. Luis Burzio, Scientific Director of GrupoBios, receives the prestigious Pasteur Biotechnology Award AMSUD 2004, for the research project "A New Family of Non-Coding Mitochondrial RNAs as Targets for Diagnosis and Cancer Therapy".

  • edit_location

    access_time 2005

    BiosChile and BiosWerfen move to a new corporate building. The new headquarters is located in the city of Santiago and comprises an area of ​​20,000 m2 with 6,000 m2 of laboratories, warehouses, manufacturing facilities and administration offices.

  • done_all

    access_time 2007

    BiosChile develops a recombinant vaccine against Piscirickettsia salmonis.

  • call_merge

    access_time 2008

    BiosChile and BiosWerfen merge into GrupoBios S.A.

  • search

    access_time 2010

    Andes Biotechnologies is formed, a spinoff of our Cancer Research area.

  • account_balance

    access_time 2012

    GrupoBios, in partnership with Bioteccel, founded BiosCell, the first bank of expanded stem cells in the country.

  • local_atm

    access_time 2016

    GrupoBios sells its share of BiosCell and focuses on developing new business lines.

Contact Us